Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02257 SIRNAOMICS-B > Detailed Quotes

02257 SIRNAOMICS-B

Watchlist
53.600
+0.900+1.71%
Market Close  02/09 16:08 CCT
High
54.750
Open
52.800
Turnover
4.24M
Low
52.350
Pre Close
52.700
Volume
78.75K
Market Cap
4.70B
P/E(TTM)
Loss
52wk High
95.600
Shares
87.72M
P/E(Static)
Loss
52wk Low
47.000
Float Cap
4.70B
Bid/Ask %
6.80%
Historical High
101.000
Shs Float
87.72M
Volume Ratio
0.87
Historical Low
47.000
Dividend TTM
--
Div Yield TTM
--
P/B
3.39
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.09%
Amplitude
4.55%
Avg Price
53.823
Lot Size
50
Float Cap
4.70B
Bid/Ask %
6.80%
Historical High
101.000
Shs Float
87.72M
Volume Ratio
0.87
Historical Low
47.000
Dividend TTM
--
P/B
3.39
Dividend LFY
--
Turnover Ratio
0.09%
Amplitude
4.55%
Avg Price
53.823
Lot Size
50
Price Forecast

News

Comment

Company Overview More
sirNomics is the first and only clinical-stage RNA therapy biopharmaceutical company with significant market positions in both China and the US. Through exploration and development of innovative drugs, they are used in human diseases with significant unmet medical needs. The clinical development pipeline focuses on oncology and fibrosis indications. Our management team shares extensive experience and ability to explore, develop, and commercialize RNAi therapies. Our mission is to be a fully integrated international biopharmaceutical company that relies on our deep experience in RNA therapy and novel delivery platform technology to rapidly discover, develop and (if approved) commercialize a range of transformative therapies and vaccines for patients suffering from a variety of rare and marketable diseases.
CEO: Yang Lu
Market: Hong Kong motherboard
Listing Date: 12/30/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist